Elizabeth A. Garofalo - 29 Sep 2021 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role: Director
Signature: /s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol: ACAD
Transactions as of: 29 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 01 Oct 2021, 17:33:29 UTC
Previous filing: 27 Sep 2021
Next filing: 05 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACAD	Common Stock	Options Exercise		+1,918			1,918	29 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACAD	Restricted Stock Units	Options Exercise	$0	+1,918	+191800%	$0.000000	1,919	29 Sep 2021	Common Stock	1,918		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
F2	The restricted stock units shall vest in two equal annual installments commencing September 29, 2021.